Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsPfizer, Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2008)
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
Full post as published by Patent Docs on March 10, 2008 (boomark / email).
Bextra Product Recall
Find a Bextra Lawyer
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Teva Animal Health Expands Ketamine Hydrochloride Recall
Teva Animal Health Expands Ketamine Hydrochloride Recall
Pfizer, Pharmacia
Found Guilty of Medicaid Fraud
Acura Pharmaceuticals, Inc. ACUR Securities Fraud
Acura Pharmaceuticals, Inc. ACUR
Pfizer
Will Pay $975,000 In Clean Air Settlement
Acura Pharmaceuticals, Inc. 401(k) / ERISA Stock Fraud
Acura Pharmaceuticals, Inc. 401(k) / ERISA Stock Fraud

Pfizer Feels Pain Over Celebrex
Teva Intends to File Lawsuit Against Generic Filer for Patent Infringement
Pharma Prosecution: CIP Breaks Priority for Restricted Claims
Potential Therapeutic Compounds Not Obvious Absent A Predictable Solution
District Court Upholds Validity of Pfizer's Accupril Patent, Rejecting Teva's Nonenablement Argument
Federal Circuit Invalidates Pfizer's Latest-Expiring Patent on Celebrex, for Double Patenting







